Ildiko Csiki, MD, PhD
Ildiko Csiki is the Director of Clinical Development at Glaxo Smith Kline where her primary research interest is drug development. Additionally, since 2012 she has been an Assistant Professor of Radiation Oncology at the University of Pennsylvania, where she has been both a clinical and laboratory Principal Investigator and a clinician with an active practice. Her primary clinical interest has been lung cancer, but she subsequently moved into B-cell lymphoid malignancies after transitioning into her current role. She graduated magna cum laude from the University of Arkansas with degrees in Biology, Psychology and Chemistry and then received her MD and PhD degrees from Vanderbilt University. She also completed an internship in Internal Medicine and a research pathway residency in Radiation Oncology at Vanderbilt.